Shandong Xinhua Pharmaceutical Company Limited 最近的每股盈餘為 $, $0.11 的預期。
Shandong Xinhua Pharmaceutical Company Limited SHNXY 上一季度的收入表現如何?
Shandong Xinhua Pharmaceutical Company Limited 上一季度的收入為 $
Shandong Xinhua Pharmaceutical Company Limited 的收入預期是多少?
根據 位華爾街分析師的預測,Shandong Xinhua Pharmaceutical Company Limited 的收入預期範圍從 $ 到 $
Shandong Xinhua Pharmaceutical Company Limited 的盈利品質評分是多少?
Shandong Xinhua Pharmaceutical Company Limited 的盈利品質評分為 /。該評分基於盈利能力、增長、現金生成與資本分配以及槓桿四個維度。
Shandong Xinhua Pharmaceutical Company Limited 何時發布財報?
Shandong Xinhua Pharmaceutical Company Limited 的下一份財報預計在 2026-01-23 發布
Shandong Xinhua Pharmaceutical Company Limited 的預期收益是多少?
根據華爾街分析師的預測,Shandong Xinhua Pharmaceutical Company Limited 的預期收益為 $
Shandong Xinhua Pharmaceutical Company Limited 是否超出收益預期?
Shandong Xinhua Pharmaceutical Company Limited 最近的收益為 $, 預期。
關鍵數據
前收市價
$18.19
開盤價
$18.19
當日範圍
$18.19 - $18.19
52週區間
$18.19 - $18.19
交易量
100
平均成交量
0
股息收益率
--
每股盈餘 (TTM)
0.80
市值
$899.9M
什麼是 SHANDONG XINHUA PHARMACEUTICAL ?
Shandong Xinhua Pharmaceutical Co Ltd is a CN-based company operating in Pharmaceuticals industry. The company is headquartered in Zibo, Shandong and currently employs 7,296 full-time employees. Shandong Xinhua Pharmaceutical Co Ltd is a China-based company mainly engaged in the development, manufacturing and sales of chemical raw materials, pharmaceutical preparations and chemical products. The firm operates three segments. The Chemical Raw Materials segment is mainly engaged in the development, manufacturing and sales of raw materials for antipyretics and analgesics such as caffeine series, ibuprofen series, aspirin series, dopamine series, barbiturates and pipemidic acid. The Pharmaceutical Preparations segment is mainly engaged in the development, manufacturing and sales of tablets, injections and capsules such as pipemidic acid tablets, aminopyrine and nimodipine tablets. The Pharmaceutical Intermediates and Other Products segment is mainly engaged in the development, manufacturing and sales of pharmaceutical intermediates and other products. The firm mainly operates its business in the domestic market and overseas markets such as the Americas and Europe.